Baird Financial Group’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-44,344
| Closed | -$233K | – | 1330 |
|
|
2017
Q4 | $233K | Sell |
44,344
-1,056
| -2% | -$5.55K | ﹤0.01% | 1181 |
|
|
2017
Q3 | $278K | Buy |
45,400
+987
| +2% | +$6.04K | ﹤0.01% | 1121 |
|
|
2017
Q2 | $321K | Buy |
44,413
+3,655
| +9% | +$26.4K | ﹤0.01% | 1069 |
|
|
2017
Q1 | $216K | Buy |
40,758
+9,880
| +32% | +$52.4K | ﹤0.01% | 1148 |
|
|
2016
Q4 | $222K | Buy |
30,878
+1,659
| +6% | +$11.9K | ﹤0.01% | 1120 |
|
|
2016
Q3 | $273K | Buy |
29,219
+18
| +0.1% | +$168 | ﹤0.01% | 1076 |
|
|
2016
Q2 | $198K | Buy |
+29,201
| New | +$198K | ﹤0.01% | 1143 |
|